查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2002639

家用透析系统市场：依治疗方法、设备类型、最终用户和分销管道划分－2026-2032年全球市场预测

Home Dialysis Systems Market by Modality, Device Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，家用透析系统市场价值将达到 272.5 亿美元，到 2026 年将成长至 302 亿美元，到 2032 年将达到 562.8 亿美元，年复合成长率为 10.91%。

主要市场统计数据
基准年 2025 272.5亿美元
预计年份：2026年 302亿美元
预测年份 2032 562.8亿美元
复合年增长率 (%) 10.91%

以患者为中心的创新、临床实践的改变以及营运模式的重新设计将如何改变家庭透析护理的提供方式，展望未来前景。

肾臟护理的发展趋势日益显着，其驱动力在于从以机构为中心的强化护理模式转向以患者为中心的居家治疗模式，后者更加重视便利性、临床疗效和生活品质。设备人体工学、耗材设计、远端监测和临床通讯协定的进步降低了居家透析的传统门槛，使更多患者和医疗服务提供者能够将居家血液透析和腹膜透析视为可行的长期照护策略。在此背景下，临床、营运和商业领域的相关人员需要重新定义他们对市场的理解，不再将其视为以机构为中心的传统模式，而是将其视为以分散式照护路径为特征的模式。

科技进步、保险公司的支持趋势以及病人偏好的改变是如何共同将家庭透析转变为去中心化、数位化驱动的照护模式的？

近年来，科技、监管和行为趋势的共同作用，为居家透析环境带来了变革性的改变。远端医疗和远距监测已从小众先导计画发展成为居家透析计画的核心要素，使临床医生能够在患者居家期间持续进行临床监督。同时，设备製造商优先考虑提高设备的便携性、简化安装流程和实现自动化安全检查，使更多患者能够享受居家透析服务。这些设计上的进步也得益于耗材和透析液管理方面的改进，从而减轻了实体储存负担并简化了更换流程。

评估 2025 年关税变化将如何促使供应链重组、加速本地采购以及改变产品设计，以确保医疗保健的连续性。

2025年关税措施的实施立即引起了人们对整个全球医疗设备供应链的关注，其中包括家用透析系统使用的组件和耗材。对进口原料、成品和专用耗材征收的关税迫使采购团队重新评估其筹资策略和供应商组合。为此，许多相关人员加快了近岸外包的步伐，实现了供应商基础的多元化，并加强了对替代供应商的审查，以降低单一来源依赖的风险并减少前置作业时间的波动。这些供应链策略调整使采购重点从追求最低成本转向优先考虑供应商的韧性和品质的持续性。

将治疗方法方案、医疗设备类型、通路和最终用户画像与投资和商业化要求联繫起来的细分市场主导洞察。

将居家透析市场进行详细细分，可清楚展现临床价值与商业性机会的交会点。依透析方式划分，市场分为家庭血液透析及居家腹膜透析。家庭血液透析又细分为常规血液透析、夜间血液透析和短时日间血液透析；而腹膜透析则细分为自动化腹膜透析和连续性移动腹膜透析。每种治疗方法及其子类别都有其独特的临床工作流程、患者培训要求和设备功能优先级，这些因素都会影响其应用趋势和支持模式。例如，设备的可靠性和隐蔽性对于夜间或过夜治疗至关重要，而快速设置和减轻看护者负担则是短时日间治疗的优先考虑因素。

区域趋势和营运实际情况决定了世界主要地区的差异化部署管道和特定区域的商业化策略。

区域趋势正在影响居家透析的普及轨迹和营运模式。在美洲，临床实务指引、报销政策和病患支持活动促成了居家透析普及的集中区域。同时，医疗保健系统的整合和对数位医疗的投资正在推动业务扩张。此外，该地区的物流网络和经销伙伴关係强调整合服务和基于价值的合同，这影响着设备和耗材的捆绑销售和报销方式。

竞争定位分析重点阐述了成熟企业、专业供应商和数位新兴企业如何透过整合临床和服务能力来重塑其价值提案。

家用透析领域的竞争动态复杂多样，既有传统的医疗设备製造商，也有专业的耗材供应商，还有专注于软体驱动型护理的数位化新兴参与企业。现有医疗设备製造商在监管合规经验、临床证据累积和成熟的分销网络方面保持优势，这些优势支撑着他们建立的大规模采购关係。而新兴参与企业则往往透过更简洁的设计、创新的耗材以及整合的远端监测功能来吸引以患者为中心的医疗项目，从而脱颖而出。

为行业领导者提供可操作的策略性倡议，以简化患者流程、加强供应链并整合数位化医疗服务，从而扩大家庭透析项目

产业领导者应优先考虑一系列切实可行的倡议，以在不断发展的居家透析生态系统中获取价值。首先，投资于能够简化患者工作流程并最大限度减少耗材处理的产品设计，从而降低患者自我用药的门槛并提高用药依从性。其次，透过建构远端监测、预测性维护和护理协调能力来加速数位化整合，从而减轻医疗专业人员的负担并实现基于结果的合约。第三，透过区域供应商认证、推广组件模组化以及探索本地组装方案来实现供应链多元化并降低风险，从而即使在贸易中断期间也能维持护理的连续性。

调查方法结合了相关人员访谈、临床文献整合和供应链分析，为家庭透析系统提供了检验且可操作的见解。

本分析的调查方法透过交叉引用与关键相关人员的访谈、医疗设备和临床文献综述、监管分析以及供应链图谱，对家庭透析系统进行了综合观点。研究人员对临床医生、供应链经理和销售主管进行了初步访谈，以确定营运限制、推广驱动因素和尚未解决的需求。除了这些定性研究结果外，研究人员还对医疗设备设计趋势、耗材创新和已发表的临床通讯协定进行了系统性回顾，以确保技术的准确性和相关性。

为了促进永续家庭透析的广泛应用，我们正在整合关键策略挑战，以协调设备创新、临床支援和供应链韧性。

总之，居家透析正处于转折点，临床进步、病患偏好和营运模式的重新设计共同为持续改善医疗服务创造了机会。居家照护的转型需要整合解决方案，这些方案应结合设备创新和培训、可靠的供应链以及与保险公司的合作。儘管贸易趋势和区域差异需要采取不同的策略，但以患者为中心、数位化驱动的护理这一基本趋势在各地区保持一致。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：家用透析系统市场：依透析方式划分

  • 居家血液透析
    • 传统血液透析
    • 夜间血液透析
    • 短期门诊血液透析
  • 腹膜透析
    • 自动腹膜透析
    • 持续性移动腹膜透析

第九章 家用透析系统市场：依设备类型划分

  • 配件
  • 消耗品
    • 透析浓缩液
    • 筛选
  • 装置

第十章 家用透析系统市场：依最终用户划分

  • 居家医疗服务提供者
  • 自我管理

第十一章：家用透析系统市场：依分销管道划分

  • 在线的
  • 零售

第十二章 家用透析系统市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 家用透析系统市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 家用透析系统市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国家用透析系统市场

第十六章：中国家用透析系统市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Allmed Medical Care Holdings Limited
  • AWAK Technologies Pte. Ltd.
  • B. Braun Avitum AG
  • Bain Medical Equipment Co., Ltd.
  • Baxter International Inc.
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Jiangsu Jihua Medical Instruments Co., Ltd.
  • JMS Co., Ltd.
  • Kawasaki Laboratories, Inc.
  • Medica SpA
  • Medical Components, Inc.
  • Medtronic plc
  • Nikkiso Co., Ltd.
  • Nipro Corporation
  • Outset Medical, Inc.
  • Quanta Dialysis Technologies Ltd.
  • Rockwell Medical, Inc.
  • SWS Hemodialysis Care
  • Toray Medical Co., Ltd.
  • Weigao Group
Product Code: MRR-0D217D5ADC94

The Home Dialysis Systems Market was valued at USD 27.25 billion in 2025 and is projected to grow to USD 30.20 billion in 2026, with a CAGR of 10.91%, reaching USD 56.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.25 billion
Estimated Year [2026] USD 30.20 billion
Forecast Year [2032] USD 56.28 billion
CAGR (%) 10.91%

A forward-looking overview of how patient-centered innovation, clinical practice shifts, and operational redesign are reshaping home dialysis care delivery

The evolution of renal care is increasingly anchored by a shift from centralized in-center treatment toward patient-centered home therapy that emphasizes convenience, clinical outcomes, and quality of life. Advances in device ergonomics, consumable design, remote monitoring, and clinical protocols have collectively reduced historical barriers to at-home dialysis, enabling more patients and providers to consider home hemodialysis and peritoneal dialysis as viable long-term care strategies. In this context, stakeholders across clinical, operational, and commercial functions must reframe their understanding of the market as one defined by distributed care pathways rather than facility-centric delivery models.

Transitioning care to the home environment introduces new imperatives for training, supply logistics, and remote clinical oversight. Consequently, manufacturers and service providers are investing in human-centered design, simplified consumables, and intuitive user interfaces that reduce cognitive load for patients and caregivers. At the same time, payers and health systems are re-evaluating reimbursement and outcomes measurement frameworks to align incentives with lower hospitalization rates and improved patient-reported outcomes. Collectively, these dynamics are catalyzing an ecosystem in which technology, policy, and clinical practice converge to widen adoption, improve adherence, and support scalable care models.

How technological advances, supportive payer dynamics, and changing patient preferences are converging to transform home dialysis into a distributed, digitally enabled care model

Recent years have seen transformative shifts in the landscape of home dialysis driven by converging technological, regulatory, and behavioral trends. Telehealth and remote monitoring have moved from niche pilot projects to core components of home dialysis programs, enabling clinicians to maintain clinical oversight while patients remain at home. Concurrently, device manufacturers have prioritized portability, simplified setup workflows, and automated safety checks, making at-home therapy more accessible to a broader patient demographic. These design advances are complemented by improvements in consumables and dialysate management that reduce physical storage burdens and simplify exchanges.

Regulatory frameworks and payer policies are evolving in parallel to support adoption, although variability across jurisdictions continues to shape local uptake. Training models have shifted from prolonged in-center instruction to blended learning approaches that combine in-home coaching with virtual refreshers, which reduces travel burdens and improves retention of skills. Patient preferences have also changed, with greater demand for therapies that accommodate work, family life, and personal autonomy. Taken together, these changes are not incremental; they represent a reorientation of renal care toward distributed, digitally enabled, and patient-centric models that require new value propositions from manufacturers, service providers, and health systems.

Assessment of how tariff shifts in 2025 prompted supply chain reconfiguration, regional sourcing acceleration, and product design changes to protect continuity of care

The introduction of tariff measures in 2025 created immediate attention across global supply chains for medical devices, including components and consumables used in home dialysis systems. Tariffs applied to imported raw materials, finished devices, and specialized consumables have pressured procurement teams to reassess sourcing strategies and supplier portfolios. In response, many stakeholders accelerated nearshoring, diversified supplier bases, and intensified qualification of alternative vendors to mitigate single-source exposure and reduce lead time volatility. These strategic supply chain adaptations have emphasized supplier resilience and quality continuity over lowest-cost sourcing.

Operationally, the tariff landscape prompted manufacturers to re-evaluate product architecture to limit reliance on high-tariff inputs, pursue component standardization, and expand localized assembly where regulatory pathways permitted. Service providers and distributors adjusted contractual terms to share risk and explore inventory buffering strategies while maintaining clinical continuity for patients. Clinicians and health systems signaled a preference for devices and consumables with robust post-market support and predictable supply chains, as interruptions directly impact continuity of care. In summary, the tariff environment served as an accelerant for supply chain redesign, driving investment into regional partnerships, inventory strategies, and design-for-manufacture approaches that prioritize operational resilience and consistent patient access.

Segment-driven insights that connect modality choices, device typologies, distribution pathways, and end-user profiles to investment and commercialization imperatives

A nuanced segmentation of the home dialysis market clarifies where clinical value and commercial opportunity intersect. Based on modality, the market divides into home hemodialysis and peritoneal dialysis, where home hemodialysis is further differentiated by conventional hemodialysis, nocturnal hemodialysis, and short daily hemodialysis, while peritoneal dialysis subdivides into automated peritoneal dialysis and continuous ambulatory peritoneal dialysis. Each modality and sub-modality presents distinct clinical workflows, patient training demands, and device feature priorities, which influence adoption vectors and support models. For example, nocturnal or overnight therapies emphasize device reliability and unobtrusive operation, whereas short daily regimens prioritize rapid setup and minimal caregiver burden.

Based on device type, the market is studied across accessories, consumables, and machines, with the consumables category further segmented into dialysate concentrates and filters. Consumables drive recurring revenue and logistics complexity, and therefore operational efficiency in distribution and supply continuity becomes a critical differentiator. Accessories and machines represent capital and service investments; devices embedded with remote diagnostics reduce lifecycle disruptions and support predictive maintenance. Based on distribution channel, the market is observed through online and retail pathways, which have different implications for patient education, fulfillment logistics, and regulatory compliance. Online channels enable direct-to-patient models and subscription-based replenishment, while retail pathways intersect with traditional medical supply networks and pharmacy partnerships.

Based on end user, the distinction between home healthcare agency and self administration underscores the importance of training, clinical oversight, and service bundles. Home healthcare agencies often require integrated reporting and multi-patient support capabilities, while self-administration models demand highly intuitive user interfaces and strong remote clinical support. Understanding these intersecting segmentation dimensions clarifies where investment in product design, patient education, and distribution infrastructure will yield the greatest clinical and commercial returns.

Regional dynamics and operational realities that determine differentiated adoption pathways and tailored commercialization strategies across major world regions

Regional dynamics influence both the adoption trajectory and the operational models that support home dialysis. In the Americas, clinical practice guidelines, reimbursement policies, and patient advocacy efforts have created concentrated pockets of home therapy adoption, while health system consolidation and digital health investments have supported scaling initiatives. In addition, logistics networks and distribution partnerships in this region emphasize integrated services and value-based contracting, which affect how devices and consumables are bundled and reimbursed.

In Europe, Middle East & Africa, fragmentation across regulatory regimes and payer structures creates a heterogeneous adoption landscape. Some countries have advanced national strategies that actively promote home therapy, while others face infrastructural constraints that limit widespread implementation. Market entrants therefore prioritize adaptable business models, local partnerships, and tailored training programs to bridge capability gaps. The Asia-Pacific region presents a combination of rapid innovation adoption in urban centers and infrastructure challenges in rural areas, prompting hybrid deployment strategies that combine pharmacy and retail networks with telehealth-enabled clinical support. Supply chain considerations, regional manufacturing hubs, and regulatory timelines further differentiate go-to-market approaches across these geographies. Taken together, regional insights underscore that scalable solutions must be adaptable to local clinical practices, reimbursement models, and supply chain realities to achieve sustainable uptake.

Competitive positioning analysis highlighting how incumbents, specialized suppliers, and digital entrants are reshaping value propositions through integrated clinical and service capabilities

Competitive dynamics in the home dialysis space are shaped by a mix of legacy medical device companies, specialized consumable suppliers, and digitally native entrants focused on software-enabled care. Incumbent device manufacturers maintain advantages in regulatory experience, clinical evidence generation, and established distribution, which support large-scale procurement relationships. At the same time, newer entrants often differentiate through design simplicity, innovative consumables, and integrated remote monitoring capabilities that appeal to patient-centric programs.

Partnerships between device makers and digital health providers are increasingly common, combining hardware with cloud-based platforms for remote monitoring, adherence tracking, and teleconsultation. Distribution partners and home healthcare agencies also play an important role in shaping adoption through training, service delivery, and inventory management. Competitive advantage increasingly depends on the ability to offer an end-to-end value proposition that addresses clinical outcomes, operational resilience, and total cost of care rather than focusing solely on unit-level device performance. As a result, companies that align product development with service models, robust supply chains, and payer engagement strategies are better positioned to capture the shifting demand toward home-based renal therapies.

Actionable strategic initiatives for industry leaders to simplify patient workflows, strengthen supply chains, and integrate digital care to scale home dialysis programs

Industry leaders should prioritize a set of actionable initiatives to capture value in an evolving home dialysis ecosystem. First, invest in product designs that simplify patient workflows and minimize consumable handling, thereby lowering the barrier to self administration and improving adherence. Second, accelerate digital integration by building remote monitoring, predictive maintenance, and care coordination features that reduce clinician burden and enable outcomes-based contracting. Third, diversify and de-risk supply chains by qualifying regional suppliers, increasing component modularity, and exploring localized assembly options to maintain continuity of care in the face of trade disruptions.

Moreover, commercial teams should develop hybrid go-to-market models that combine online fulfillment with retail and home healthcare partnerships to meet varied patient access patterns. Training and support must be reframed as a core service offering, embedding blended learning and competency assessments to ensure safe self administration. Finally, engage proactively with payer stakeholders to demonstrate the value of home modalities through real-world evidence and patient-reported outcomes, thereby aligning reimbursement with long-term clinical benefit. Taken together, these recommendations provide a pragmatic blueprint for organizations seeking to scale home dialysis programs while managing operational risk and delivering measurable clinical value.

Methodological approach combining stakeholder interviews, clinical literature synthesis, and supply chain analysis to deliver validated, actionable insights on home dialysis systems

The research methodology underpinning this analysis triangulates primary stakeholder interviews, device and clinical literature review, regulatory analysis, and supply chain mapping to produce an integrated perspective on home dialysis systems. Primary interviews were conducted with clinicians, supply chain leads, and commercial executives to surface operational constraints, adoption drivers, and unmet needs. These qualitative insights were complemented by a systematic review of device design trends, consumable innovations, and published clinical protocols to ensure technical accuracy and relevance.

Supply chain analysis included component sourcing, logistics pathways, and tariff impacts to elucidate operational levers and risk exposures. Additionally, payer and reimbursement frameworks were examined to understand incentives and barriers to adoption across major regions. The methodological approach emphasizes transparency in assumptions and traceability of insights, enabling stakeholders to adapt findings to their organizational context. Where applicable, sensitivity checks and validation conversations with independent experts were used to corroborate key themes and ensure the analysis reflects current industry practice and emerging developments.

Synthesis of key strategic imperatives that align device innovation, clinical support, and supply chain resilience to advance sustainable home dialysis adoption

In conclusion, the home dialysis landscape is at an inflection point where clinical advances, patient preferences, and operational redesign converge to create durable opportunities for improved care delivery. The shift toward home-based therapies requires integrated solutions that marry device innovation with training, supply chain reliability, and payer engagement. While trade dynamics and regional variability necessitate differentiated strategies, the underlying trend toward patient-centered, digitally enabled care remains consistent across geographies.

Organizations that respond by simplifying user experience, investing in remote clinical capabilities, and strengthening supply chain resilience will be best positioned to deliver sustained clinical and commercial value. Collaboration across manufacturers, payers, providers, and distributors will be essential to unlock the full potential of home dialysis as a mainstream care pathway. As stakeholders refine their strategies, ongoing evidence generation and adaptive operational models will provide the foundation for safe, scalable, and patient-preferred renal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Dialysis Systems Market, by Modality

  • 8.1. Home Hemodialysis
    • 8.1.1. Conventional Hemodialysis
    • 8.1.2. Nocturnal Hemodialysis
    • 8.1.3. Short Daily Hemodialysis
  • 8.2. Peritoneal Dialysis
    • 8.2.1. Automated Peritoneal Dialysis
    • 8.2.2. Continuous Ambulatory Peritoneal Dialysis

9. Home Dialysis Systems Market, by Device Type

  • 9.1. Accessories
  • 9.2. Consumables
    • 9.2.1. Dialysate Concentrates
    • 9.2.2. Filters
  • 9.3. Machines

10. Home Dialysis Systems Market, by End User

  • 10.1. Home Healthcare Agency
  • 10.2. Self Administration

11. Home Dialysis Systems Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Retail

12. Home Dialysis Systems Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Home Dialysis Systems Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Home Dialysis Systems Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Home Dialysis Systems Market

16. China Home Dialysis Systems Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Allmed Medical Care Holdings Limited
  • 17.6. AWAK Technologies Pte. Ltd.
  • 17.7. B. Braun Avitum AG
  • 17.8. Bain Medical Equipment Co., Ltd.
  • 17.9. Baxter International Inc.
  • 17.10. DaVita Inc.
  • 17.11. Fresenius Medical Care AG & Co. KGaA
  • 17.12. Infomed SA
  • 17.13. Jiangsu Jihua Medical Instruments Co., Ltd.
  • 17.14. JMS Co., Ltd.
  • 17.15. Kawasaki Laboratories, Inc.
  • 17.16. Medica SpA
  • 17.17. Medical Components, Inc.
  • 17.18. Medtronic plc
  • 17.19. Nikkiso Co., Ltd.
  • 17.20. Nipro Corporation
  • 17.21. Outset Medical, Inc.
  • 17.22. Quanta Dialysis Technologies Ltd.
  • 17.23. Rockwell Medical, Inc.
  • 17.24. SWS Hemodialysis Care
  • 17.25. Toray Medical Co., Ltd.
  • 17.26. Weigao Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME DIALYSIS SYSTEMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME DIALYSIS SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY NOCTURNAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY NOCTURNAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY NOCTURNAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SHORT DAILY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SHORT DAILY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SHORT DAILY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE CONCENTRATES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE CONCENTRATES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DIALYSATE CONCENTRATES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEALTHCARE AGENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEALTHCARE AGENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEALTHCARE AGENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 134. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 135. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 137. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. GCC HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 157. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 159. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. G7 HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 165. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 167. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 169. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. NATO HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL HOME DIALYSIS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY HOME HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA HOME DIALYSIS SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)